A new radiotherapy clinical trial aimed at reducing the side-effects of prostate cancer treatment will recruit 136 patients from across the island of Ireland over the next two years. The INSPIRE study ...

Men with prostate cancer are to be the subjet of a major new all-Ireland trial which aims to reduce the side-effects of radiotherapy. The aim is to reduce the impact on patients’ urinary function, ...

The trial will focus on men with localised prostate cancer who will be treated with stereotactic ablative radiotherapy (SABR) A new radiotherapy clinical trial aimed at reducing the side-effects of ...

Our website is temporarily unavailable in your location. We are working hard to get it back online. The INSPIRE study will link cancer centres across the island, with sites in Dublin, Cork, Galway, ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...

At the 2024 ESMO Congress, an expert explained how Nubeqa may reduce fatigue-related side effects in metastatic hormone-sensitive prostate cancer. Newer treatments for metastatic hormone-sensitive ...

The Alliance for Clinical Trials in Oncology is now enrolling patients in the ASPIRE trial (A032302)-a large-scale, phase III ...

Outstanding PBM priorities include banning Medicaid spread pricing, extending protections to employer-sponsored plans, and ...

Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...